Topamax "Doctor For A Day" Program Drove Off-Label Settlement
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J's Ortho-McNeil subsidiary pays a criminal fine as part of company's $81 million settlement with the Department of Justice; one doctor made more than $500,000 making office visits with sales reps.
You may also be interested in...
J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision
Janssen subsidiary pleads guilty as part of $2.2 billion deal that also requires audits of sales rep compensation.
The Era Of Billion Dollar Pharma Settlements
Abbott Laboratories is the third pharmaceutical company to reach a settlement with the Department of Justice in excess of $1 billion. A look at the deals struck since Eli Lilly began the billion dollar club in 2009 shows the activities the government is investigating and the level of liability that companies face.
Novartis Inks Second Off-Label Settlement With DoJ, Paying $72.5 Million Over TOBI Marketing
Novartis still faces government investigations over its marketing of five other drugs; FDA issues a warning letter over its promotion of Gleevec on two company-sponsored websites.